| Cutaneous Melanoma studied in …STUDIED_INderived200 of 241show all (up to 200) |
|---|
| → studied in | NCT07519655Phase 1 · recruiting Phase 1 Study of PF-08046033 in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07068074Phase 3 · recruiting Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621614Phase 2 · recruiting A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04708418Phase 2 · active not recruiting A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06014086Phase 1 · completed Intratumoral PH-762 for Cutaneous Carcinoma · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05267626Phase 1/Phase 2 · recruiting Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07576725Phase 2 · not yet recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01303341Phase 1 · active not recruiting Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02196181Phase 2 · active not recruiting Testing Two Different Treatment Schedules of Dabrafenib and Trametinib for Skin Cancer Which Has Spread · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04462406Phase 2 · active not recruiting Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04511013Phase 2 · recruiting A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05358938early Phase 1 · active not recruiting Exercise to Boost Response to Checkpoint Blockade Immunotherapy · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00937937Phase 2 · active not recruiting Dinaciclib in Treating Patients With Stage IV Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01134614Phase 2 · active not recruiting Ipilimumab With or Without Sargramostim in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01720407Phase 3 · completed Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Lentigo Maligna Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059444recruiting ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01480154Phase 1 · active not recruiting Akt Inhibitor MK2206 and Hydroxychloroquine in Treating Patients With Advanced Solid Tumors, Melanoma, Prostate or Kidney Cancer · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05903937Phase 1 · not yet recruiting Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07183852Phase 1 · not yet recruiting Locoregional or Systemic Administration of Autologous Tumor Infiltrating Lymphocytes in Patients With Metastatic Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01274338Phase 3 · active not recruiting Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07807878Phase 2 · not yet recruiting Trial of Temozolomide in BAP1 Mutated Patients With Advanced or Metastatic Cutaneous Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03021460Phase 1 · completed Pembrolizumab and Ibrutinib in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02339571Phase 2/Phase 3 · active not recruiting A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02506153Phase 3 · active not recruiting Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03025256Phase 1 · active not recruiting Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07600476Phase 1 · recruiting A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02581930Phase 2 · completed Ibrutinib in Treating Patients With Refractory Metastatic Cutaneous Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07757386NA · completed MelaMEd Online Training for General Practitioners to Improve Melanoma Detection and Management · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02231775Phase 2 · active not recruiting Dabrafenib and Trametinib Before and After Surgery in Treating Patients With Stage IIIB-C Melanoma With BRAF V600 Mutation · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04855435Phase 1 · recruiting Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04221438Phase 2 · terminated Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04356729Phase 2 · active not recruiting A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03698019Phase 2 · active not recruiting A Study to Compare the Administration of Pembrolizumab After Surgery Versus Administration Both Before and After Surgery for High-Risk Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05098210Phase 1 · recruiting Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01708941Phase 2 · completed Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07230613Phase 2 · recruiting Neo-adjuvant Immunotherapy in Patients With Localized Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03384836Phase 1/Phase 2 · suspended Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06307093Phase 1 · completed Study Comparing the Pharmacokinetics, Safety, and Efficacy of RPH-075 and Keytruda® in Patients With Malignant Neoplasms · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06320353Phase 3 · completed Study сomparing the Efficacy and Safety of RPH-075 and Keytruda® in Patients With Unresectable or Metastatic Skin Melanoma · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07631325Phase 1/Phase 2 · not yet recruiting Axelopran and Nivolumab in PD-1-Refractory Metastatic Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06984328Phase 2 · terminated Study of the Effectiveness and Safety of Acasunlimab Alone and With Pembrolizumab to Treat Advanced Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07) · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02775851Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Desmoplastic Melanoma That Can or Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Desmoplastic Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07680699recruiting NEOSENT: Early Anti-PD-1 Therapy In High-Risk Stage II Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05571839Phase 1 · terminated A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07671495Phase 2 · completed Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05520099active not recruiting Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform (ELEPHAS-02) · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07049276NA · recruiting The Multicentre Selective Lymphadenectomy Trial - 3 · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01989572Phase 3 · completed Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07354152recruiting COmparison of the Use of a PERforator Flap Versus Total Skin GRAft in the Management of Loss of Substance After Resection of Cutaneous Melanoma - Pilot Study · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04734704NA · terminated Defining the Role of the Skin Microbiome in Immune-related Adverse Events · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04702854NA · terminated Evaluation of Ultrasound Biomicroscopy in the Local Staging of Cutaneous Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06967961NA · recruiting Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02910700Phase 2 · active not recruiting Nivolumab With Trametinib and Dabrafenib, or Encorafenib and Binimetinib in Treating Patients With BRAF Mutated Metastatic or Unresectable Stage III-IV Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06265285Phase 2 · recruiting Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03947385Phase 1/Phase 2 · recruiting Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07628894Phase 1 · not yet recruiting Circadian-Optimized Light Therapy for the Treatment of Patients With Advanced Melanoma Receiving Tumor-Infiltrating Lymphocyte Therapy · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06319196Phase 2 · recruiting Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07627698Phase 1/Phase 2 · recruiting Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06391099NA · suspended Ketogenic Dietary Intervention to Improve Response to Immunotherapy in Patients With Metastatic Melanoma and Metastatic Kidney Cancer · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05186753Phase 2 · active not recruiting (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Low-CSD Melanoma, Superficial Spreading Melanoma Subtype | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02965716Phase 2 · active not recruiting Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04253080NA · completed Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04778449recruiting Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06624644Phase 2/Phase 3 · recruiting A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01955460Phase 1 · active not recruiting Genetically Modified T-Cells Followed by Aldesleukin in Treating Patients With Stage III-IV Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03699995NA · terminated MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05628883Phase 1 · completed Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03620019Phase 2 · completed Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06008977NA · active not recruiting Exercise to Boost Response to Checkpoint Blockade Immunotherapy · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03420963Phase 1 · terminated Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03276832early Phase 1 · completed Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04119024Phase 1 · recruiting Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06221397completed AI-based Medical Device Validation for Early Melanoma Detection · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06223659Phase 2 · recruiting EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02858869Phase 1 · completed Pembrolizumab and Stereotactic Radiosurgery for Melanoma or Non-Small Cell Lung Cancer Brain Metastases · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04020809Phase 1 · active not recruiting Neoadjuvant Atezolizumab in Cutaneous Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04792463recruiting Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03716193NA · terminated Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06305962early Phase 1 · recruiting 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06999980Phase 2 · recruiting Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation) · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03767348Phase 2 · active not recruiting Study of RP1 Monotherapy and RP1 in Combination With Nivolumab (IGNYTE) · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03543969early Phase 1 · active not recruiting Adaptive BRAF-MEK Inhibitor Therapy for Advanced BRAF Mutant Melanoma · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07376317Phase 2 · active not recruiting Optimization of Immunotherapy Treatment for Advanced Melanoma in the Context of the Public Brazilian Health System (OTIMAS) · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07347444Phase 2 · not yet recruiting Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03028948NA · completed Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06946225Phase 1 · recruiting ACTengine® IMA203 Combined With mRNA-4203 · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05544929Phase 1 · active not recruiting A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03929029Phase 1 · active not recruiting Neoantigen Vaccine Plus Locally Administered Ipilimumab and Systemic Nivolumab in Advanced Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06994208recruiting Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age. · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07251335recruiting Melanoma of the Skin and Exposure to Solar Ultraviolet Radiation at Work in Modena Territory: a Case-control Study to Promote an Active Search and Prevention of Occupational Diseases Based on Recent INAIL Criteria · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01950390Phase 2 · completed Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05675709NA · completed Enhancing Skin Cancer Early Detection and Treatment in Primary Care · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06194929Phase 1/Phase 2 · recruiting Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06784648Phase 1/Phase 2 · active not recruiting Different Doses of BI-1607 in Combination With Pembrolizumab and Ipilimumab, in Participants With Unresectable or Metastatic Melanoma · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07155317Phase 2 · recruiting Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07148245recruiting Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04812470Phase 1 · completed Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes in Patients With Melanoma and Liver Metastases · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02831634NA · completed A Feasibility Study to Identify T-cell Responses to Neo-epitopes in Tumor Invaded Lymph Nodes (NeoEpitope) · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05578872Phase 1/Phase 2 · completed A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1). · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07130032Phase 2 · recruiting Efficacy And Safety Of Anti-PD-1/PD-L1 Antibodies In Combination With Bevacizumab And Metronomic Cyclophosphamide In Patients With Non-Small Cell Lung Cancer And Cutaneous Melanoma Previously Treated With Immune Checkpoint Blockade · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03611868Phase 1/Phase 2 · active not recruiting A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06754904NA · recruiting Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05086692Phase 1/Phase 2 · recruiting A Beta-only IL-2 ImmunoTherapY Study · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06654999completed How Consistent is the Output of DERM, When Used to Assess Images of Potentially Cancerous Skin Lesions. · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07031830recruiting APA (Adapted Physical Activity) for Patients With Advanced Melanoma · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03325101Phase 1/Phase 2 · terminated Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04830124Phase 2 · terminated Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6 · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05970497Phase 1/Phase 2 · recruiting A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02318771Phase 1 · completed Radiation Therapy and MK-3475 for Patients With Recurrent/Metastatic Head and Neck Cancer, Renal Cell Cancer, Melanoma, and Lung Cancer · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06965231Phase 2 · recruiting Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06952400recruiting The Registry Study of Genetic Alterations of Melanoma in Taiwan · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma of the Extremity | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03719131Phase 2 · active not recruiting Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02875132Phase 2 · completed Pembrolizumab in Advanced/Metastatic Acral Lentiginous Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04706962Phase 1 · active not recruiting TH1902 in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06625918NA · completed Effects of Ultraviolet B Exposure Using a Ultraviolet Skin Care Device on Vitamin D Production and Immune Response in Healthy Adults · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06014619active not recruiting Complications and Recurrences After Mohs Micrographic Surgery and Slow Mohs · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Lentigo Maligna Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05436990Phase 2 · terminated Antitumor Activity of Vactosertib in Combination With Pembrolizumab in Acral and Mucosal Melanoma Patients Progressed From Prior Immune Check Point Inhibitor · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05576077Phase 1 · terminated A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03761017Phase 1 · completed MGD019 DART® Protein in Unresectable/Metastatic Cancer · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05512481Phase 2 · recruiting Camrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06784778recruiting Observational Study of Patients With Advanced Melanoma (Skin Cancer) to Assess if IOpener®-Melanoma Test Can Predict Response to Immunotherapy. · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06605417recruiting Understanding the Transition from Normal Melanocytes to Nevus to Melanoma · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05669430Phase 1/Phase 2 · recruiting A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04254107Phase 1 · terminated A Safety Study of SEA-TGT (SGN-TGT) in Advanced Cancer · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01638533Phase 1 · completed Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06809491active not recruiting One-year Recurrence-free Survival of Melanoma Patients Eligible for a Sentinel Lymph Node Biopsy · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03154190NA · completed Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02500576Phase 2 · completed Pembrolizumab, Standard Chemotherapy, Tumor Infiltrating Lymphocytes, and High- or Low-Dose Aldesleukin in Treating Patients With Metastatic Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01902173Phase 1/Phase 2 · completed Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03033576Phase 2 · completed Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01973322Phase 2 · completed Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06765850recruiting The Study Aims to Measure the Metabolome in Melanoma Patients Using NMR Spectroscopy and Gas Chromatography and to Analyse Differences Depending on the Course of the Disease. · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06767332NA · recruiting EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Hereditary Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06090266Phase 1/Phase 2 · recruiting A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04375527Phase 2 · terminated Binimetinib and Nivolumab for the Treatment of Locally Advanced Unresectable or Metastatic BRAF V600 Wildtype Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02385214NA · active not recruiting MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma by AJCC v7 Stage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03860883NA · recruiting Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05824975Phase 1/Phase 2 · recruiting A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08) · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05169957Phase 1 · completed Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I) · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06666790NA · recruiting DermaSensor Postmarket Surveillance Study · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06661577not yet recruiting An Observational Study Using The LumAssure Device In Participants Undergoing Assessment Of Skin Conditions. · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02097225Phase 1 · terminated Onalespib, Dabrafenib, and Trametinib in Treating Patients With BRAF-Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01740557Phase 1/Phase 2 · completed Genetically Modified Therapeutic Autologous Lymphocytes Followed by Aldesleukin in Treating Patients With Stage III or Metastatic Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02791334Phase 1 · completed A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05200143Phase 2 · terminated Study of Ipilimumab, Nivolumab, and Cabozantinib in Patients With Cutaneous Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06602648recruiting MELCAYA - Novel Health Care Strategies for Melanoma in Children, Adolescents, and Young Adults - Work Package 3 (WP3) · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02431676Phase 2 · completed Survivorship Promotion In Reducing IGF-1 Trial · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04853602available IFx-Hu2.0 Expanded Access Program · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05079113completed Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03842943Phase 2 · recruiting Neoadjuvant Combination Immunotherapy for Stage III Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05050006Phase 2 · terminated ITIL-168 in Advanced Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02519322Phase 2 · completed Neoadjuvant and Adjuvant Checkpoint Blockade · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02978443Phase 2 · terminated A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03727789Phase 1 · terminated CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma of the Extremity | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03590054Phase 1 · completed Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor Malignancies · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06299878unknown MelPRO-0322 (CRISTINA Trial) [miCrobiome pRedIctS aPD1 effecTivnes In melaNoma pAtietns] · condition mapped ALIAS · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482074Phase 2 · withdrawn Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2 · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04244552Phase 1 · terminated A Phase 1b Trial of ATRC-101 in Adults With Advanced Solid Malignancies · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Acral Lentiginous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03229278Phase 1 · completed Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06152367Phase 1/Phase 2 · completed Immunization With Autologous Dendritic Cells and Tumor Lysates in Melanoma Patients · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01942603active not recruiting Minimal SN Tumor Burden · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02304458Phase 1/Phase 2 · completed Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05789043Phase 3 · recruiting Camrelizumab in Combination With Apatinib and Temozolomide as First-line Treatment in Advanced Acral Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02748564Phase 2 · terminated Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05253872NA · recruiting The MELAcare Study: A New Method for Surveillance of Melanoma Patients · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04042480Phase 1 · terminated A Study of SGN-CD228A in Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03843593completed A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05219578Phase 1/Phase 2 · terminated RTX-224 Monotherapy in Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05572463Phase 1/Phase 2 · withdrawn A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01807182Phase 2 · completed Tumor-Infiltrating Lymphocytes After Combination Chemotherapy in Treating Patients With Metastatic Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03396952Phase 2 · completed Prostaglandin Inhibition and Immune Checkpoint Blockade in Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00679289Phase 2 · completed Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04551352Phase 1 · completed A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03655756early Phase 1 · completed pDNA Intralesional Cancer Vaccine for Cutaneous Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02857374NA · completed Intravital Microscopy in Identifying Tumor Vessels in Patients With Stage IB-IIIC Melanoma Undergoing Sentinel Lymph Node Biopsy · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01744171Phase 1 · terminated Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03633110Phase 1/Phase 2 · completed Safety, Tolerability, Immunogenicity, and Antitumor Activity of GEN-009 Adjuvanted Vaccine · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02437279Phase 1 · unknown Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01940809Phase 1 · terminated Ipilimumab With or Without Dabrafenib, Trametinib, and/or Nivolumab in Treating Patients With Melanoma That Is Metastatic or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02288897Phase 3 · terminated PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01511913completed A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02716948Phase 1 · completed SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or Spine · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02129075Phase 2 · completed A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02355574terminated 5-year Study to Track Clinical Application of DecisionDx-Melanoma Gene Expression Profile Assay Results · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02355587terminated Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03663647completed Advanced Melanoma in Russian Experience · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04331093Phase 2 · recruiting Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Acral Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03112668NA · completed Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03425461Phase 1 · terminated Anti-SEMA4D Monoclonal Antibody VX15/2503 With Nivolumab or Ipilimumab in Treating Patients With Stage III or IV Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04789421NA · completed Advanced Non-invasive Diagnostics for Early Cutaneous Tumor Diagnosis, Clinical-therapeutic and Economic Management · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04625491unknown Location of Lower Limb Cutaneous Melanomas as a Prognostic Factor. · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01886235NA · completed Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02968680Phase 1 · terminated Sonazoid-Enhanced Ultrasound in Detecting Sentinel Lymph Node in Patients With Cutaneous Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04274816Phase 1 · completed Intradermal Injection of Anti-CTLA-4 in Patients With Stage I/II Melanoma · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01970527Phase 2 · terminated Phase II Trial of Stereotactic Body Radiotherapy Followed by Ipilimumab in Treating Patients With Stage IV Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02587650Phase 2 · terminated Capmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02320305early Phase 1 · completed MART-1 Antigen With or Without TLR4 Agonist GLA-SE in Treating Patients With Stage II-IV Melanoma That Has Been Removed by Surgery · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03628417NA · completed Confirmatory Trial in the Evaluation of Ca Electroporation for the Treatment of Cutaneous Metastases · condition mapped ONTOLOGY_EXACT · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01196416Phase 1/Phase 2 · completed Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01789827early Phase 1 · completed Aldesleukin Imaging in Viewing Tumor Growth in Patients With Stage IV Melanoma Receiving Ipilimumab or Pembrolizumab Therapy · condition mapped CURATED_BROADER · 241 trials mapped (97 active) | — | — | Cutaneous Melanoma | 1 | Observed | clinicaltrials | graph → |